| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0005 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |